Massachusetts Department of Public Health

Slides:



Advertisements
Similar presentations
SWEDRES 2001 Figures and Tables. 3. Use of antimicrobials.
Advertisements

The Oregon POLST Registry For HIM Departments & Clinic Support Staff.
Tick-borne Disease Surveillance Catherine M. Brown, DVM, MSc, MPH State Public Health Veterinarian Massachusetts Department of Public Health.
Instructions and Reporting Requirements Module 3 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Antimicrobial resistance surveillance in Ireland Results of invasive Staphylococcus aureus infection (blood) surveillance (2009Q1-4) **** Data as of 14/04/2010.
Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.
Deepthi Rajeev, MS, MSc Department of Biomedical Informatics University of Utah Evaluating the Impact of Electronic Disease Surveillance Systems On Local.
Enoch Omonge University of Nairobi
Antimicrobial Resistance Surveillance Latin America
MANUAL on ALERT ORGANISM SURVEILLANCE
WHONET Part II Expert System Dr.T.V.Rao MD 1. Isolate alerts WHONET now permits the user to take advantage of pre-defined or user-defined expert rules.
WHO Global Salm-Surv: A Global Salmonella Surveillance Network World Health Organization, Geneva Centers for Disease Control and Prevention, Atlanta Danish.
1. Fung-Tomc J, Minassian B, Kloek B, et al. (2000). Antibacterial spectrum of a novel des-Fluoro (6) quinolone, BMS Antimicrobial Agents and Chemotherapy.
The Use of Cefoxitin for the Determination of Methicillin Resistance in Staphylococci John D. Perry Microbiology Department Freeman Hospital Newcastle.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
Tracking from Birth: Massachusetts Universal Newborn Hearing Screening Program MCHB/CDC Annual Meeting on Successful Statewide EHDI Programs Presenter:
MRSA in Corrections Danae Bixler, MD, MPH
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
Methods Revised Abstract Methods Results TP-271 is a Potent, Broad-Spectrum Fluorocycline with Activity Against Community-Acquired Bacterial Respiratory.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Aims of study This surveillance study was performed to determine the in vitro activity of ciprofloxacin against clinical isolates of Escherichia coli and.
Baltimore Update: SSuN, Challenges in implementation Clinic-based dataset: – Existing clinic data system (Insight™) – Minimal barriers to electronic.
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Interpretation/Evaluation of Laboratory Data CLS 552 Human Microbiology & Immunology Laboratory Note: View this PowerPoint as a ‘Full Screen Slide Show’.
© 2009 CSTS: The Cardiovascular Surgical Translational Study Using the Centers for Disease Control and Prevention’s National Healthcare Safety Network.
School of Health Sciences Week 4! AHIMA Practice Brief Fundamentals of Health Information HI 140 Instructor: Alisa Hayes, MSA, RHIA, CCRC.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
Listing Antimicrobial Resistant Pathogens of Public Health Importance Implications for Drug Development Listing Antimicrobial Resistant Pathogens of Public.
Points for Discussion Anti-Infective Drugs Advisory Committee Meeting March 5, 2003.
Supplemental testing methods
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
* required for saving Tracking #: Facility ID:*Survey Year: Facility Characteristics *Ownership (check one): □ For profit □ Not for profit, including church.
Part II High Priority Resistant Organisms. Healthcare Associated Infections NHSN Staphylococcus aureus (16%) 2.Enterococcus spp (14%) 3.Escherichia.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Figure 1. Rate of antimicrobial resistance in S. pneumoniae
Etiology of bacteremia in children under 5 years in Southern Mali
Point Prevalence Survey in a Long Term Care Facility, 2016
Using the Oregon POLST Registry
Dr.Mowna Karthick M.D MICROBIOLOGY
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
Average susceptibility
The Oregon POLST Registry
Vibrio Reporting and Surveillance in Louisiana
Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.
This is an archived document.
Chapter 1: Introduction to Multidrug – Resistant Organisms
Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients  C. Andersen, B.C. Kahl,
Antibiograms: “What and Why?”
Hospital Antibiotic Stewardship Programs
Using the Oregon POLST Registry
Neonatal sepsis in Kilifi
WHONET علیرضا ترکی دانشجوي PhD ميکروب شناسی بالینی
The Oregon POLST Registry
…monitoring trends in antimicrobial resistance in Canada
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
Presentation transcript:

Massachusetts Department of Public Health National Guidelines and Statewide Antimicrobial Susceptibility Testing, Reporting and Surveillance In Massachusetts Barbara Bolstorff Kerri Barton Johanna Vostok Hilary Placzek Lynda Glenn Alfred DeMaria Massachusetts Department of Public Health

Antibiograms Antibiograms, generated by hospital microbiology laboratories, report the susceptibility of bacterial isolates tested against specific antibiotics (usually aggregated by year). The Massachusetts Department of Public Health (MDPH) has requested hospitals in Massachusetts send antibiograms since 1999.

Antibiograms in Massachusetts Since 2002, MDPH has received an average of 53 antibiograms per year (range 43-57) from 71-73 facilities. Organisms routinely reported include: Acinetobacter baumannii Staphylococcus aureus Pseudomonas aeruginosa Methicillin-resistant Staphylococcus aureus Escherichia coli Klebsiella pneumoniae Serratia marcescens Stenotrophomonas maltophilia Enterobacter cloacae Klebsiella oxytoca Enterobacter aerogenes Streptococcus pneumoniae

Antibiogram example 4

Antibiograms submitted by hospitals in a wide variety of formats, often not following CLSI guidelines 5

Data collection 1999-2011 An email is sent to all acute-care hospital microbiology supervisors each year (Feb-March) requesting the previous year’s antibiogram data Prior to electronic submission form (2012) Data were received in a variety of formats, usually through email, fax, or snail mail Missing information (i.e. patient type, duplicate isolate reporting) required a follow-up phone call Data were entered manually into a large Microsoft Office Access Database and analyzed using SAS

Data entry 1999-2011

CLSI (Clinical and Laboratory Standards Institute) Documents that provide laboratories with guidance for standardization Antibiograms: Developing Cumulative Reports for Your Clinicians: M39-A: 2002 M39-A2: 2005 M39-A3: 2009 M39-A4: ? http://www.clsi.org/

CLSI adherence in MA MDPH evaluated antibiogram data from 2002-2010 Focused on 5 important recommendations from CLSI 1- Exclude duplicate bacterial isolates (2002) 2- Separate reporting of Staphylococcus aureus isolates by methicillin (oxacillin)-susceptibility (2002) 3- Format of data into a grid (2002) 4- Report species only when 30 or more isolates are tested annually (2005) 5- Summarize data by patient type (2005)

Reporting of Duplicate Results and <30 Isolates Exclusion of duplicate bacterial isolates increased from 67% in 2005 to 93% in 2008 and has remained constant.

Reporting a S. aureas only, MRSA and MSSA Separately and Total Plus MRSA and MSSA Separate reporting of S. aureus susceptibilities increased from 20% in 2002 to 50% in 2010.

Results, cont’d. In 2010, 80% of submitted antibiograms were in a one-page grid format, consistent with the CLSI recommendation Hospitals reporting organisms isolated <30 times per year decreased from 86% in 2002 to 57% in 2010 During the time period from 2002 to 2010: Hospitals consistently reported all patient isolates (range: 63-78% ) Range of hospitals that reported inpatient only isolates: 22-31% Less than 10% of hospitals reported ICU isolate data separately

Data collection 2012 and beyond An email is sent to all acute-care hospital microbiology supervisors with a standardized electronic submission form Each hospital is asked to enter their data into the form (using Adobe Reader for free) and electronically submit the data via email submission At MDPH: Each form is downloaded from the email, data are extracted using Adobe Acrobat, and analyzed using SAS

2013 Submission Form

Required fields Electronically submit Save the form to shared email account Save the form for later use

“Rules” built into form

Variable “N” entry

S. pneumoniae reporting

Challenges and Lessons Learned IT issues within the hospital laboratory created barriers In most cases, the latest version Adobe Reader had to be downloaded Free program, but IT services do not regularly update laboratories with new programs The new electronic submission process should have been first piloted with a select few “consistent reporters” Changes to be made: we need to

Final Product MDPH creates annual reports for every acute-care hospital in Massachusetts Report shows the state mean susceptibilities of 11 organisms of interest for a variety of antibiotics Hospitals that submit data receive a report showing their hospital-level data compared to the state mean data

Give 1-2 examples of staph aureus and e coli state mean susceptibilities and hospital data

Additional data analysis MDPH creates annual reports for every acute-care hospital in Massachusetts Data monitored over time for trends in susceptibility S. aureus and oxacillin E. coli and fluoroquinolones 24

Staphylococcus aureas Susceptibility to Oxacillin Over Time, Massachusetts Antibiograms Caveats: Hospitals reporting varies somewhat over time Changes in handling of duplicate isolates

Escherichia coli Susceptibility to Ciprofloxacin and Levofloxacin Over Time

Standardized data In order to aggregate data across hospitals, antibiograms must be standardized: MRSA and MSSA susceptibilities should be presented separately Report the first isolate tested per patient only (regardless of body site) Report separate tables for gram-negative, gram-positive, and if applicable anaerobic bacteria and yeasts

CLSI Guidelines Standard antimicrobial susceptibility testing and reporting are equally as important CLSI (Clinical Laboratory Standards Institute) for the most up-to-date recommendations: M100-S22: Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement M39-A3: Antibiograms: Developing Cumulative Reports for Your Clinicians Quick Guide (M39-A3 QG) http://www.clsi.org/

Regulatory Change Proposed requirement for submission of antibiogram data: 105 CMR 300.171: Reporting of Antimicrobial Resistant Organisms and Cumulative Antibiotic Susceptibility Test Results (Antibiograms) (B) All hospitals shall report annual cumulative antibiotic susceptibility test results (antibiograms). This report shall include information specified by the Department and be sent in the manner deemed acceptable by the Department.

Massachusetts Department of Public Health Questions? Alfred DeMaria Jr., MD Massachusetts Department of Public Health alfred.demaria@state.ma.us